24.4.05 - Semaglutide versus Tirzeparide: il confronto è iniziato

from Med Magazine · host Regia Congressi Editore

Il nuovo episodio mette vis-a-vis due farmaci, aventi come scopo principalmente il trattamento del diabete di tipo 2 e, più recentemente, la gestione del peso nei pazienti obesi. Tirzeparìde sembra più efficace nel far perdere peso, ma Semaglutìde ha un profilo di sicurezza più noto. Quale sarà da preferire?

Episode metadata supplied by the publisher feed · Published Dec 1, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

24.4.05 - Semaglutide versus Tirzeparide: il confronto è iniziato

0:00 7:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Med Magazine?

This episode is 7 minutes long.

When was this Med Magazine episode published?

This episode was published on December 1, 2024.

Can I download this Med Magazine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!